Cardiovascular Risk Associated with Inflammatory Bowel Disease: Emphasis on Lipid Levels and Visceral Fat Distribution

Overview

Patients with inflammatory bowel disease (IBD) face an increased risk of atherosclerotic cardiovascular disease (ASCVD) that is not fully explained by traditional risk factors. This review highlights the association between chronic systemic inflammation, lipid abnormalities, and visceral fat distribution in enhancing cardiovascular risk in IBD patients.

Background

Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, are recognized as systemic diseases with significant cardiovascular implications. The rising prevalence of IBD and its association with increased cardiovascular risk necessitate a deeper understanding of the underlying mechanisms and risk factors.

Data Highlights

No numerical data provided in the source material.

Key Findings

• IBD patients have an increased risk of ASCVD, particularly during active intestinal inflammation.
• Chronic systemic inflammation contributes to endothelial dysfunction and accelerated atherogenesis.
• The 'lipid paradox' describes reduced circulating lipid levels alongside increased cardiovascular risk due to inflammation-mediated changes in lipid metabolism.
• Visceral fat dysfunction and dysbiosis of the gut microbiome are linked to cardiovascular risk in IBD.
• Current strategies for cardiovascular risk assessment in IBD may underestimate risk.

Clinical Implications

Healthcare providers should consider the systemic nature of IBD when assessing cardiovascular risk.

Conclusion

Understanding the cardiovascular risks associated with IBD is crucial.

Related Resources & Content

1. Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU) position paper on cardiovascular disease in patients with inflammatory bowel disease | Gastroenterología y Hepatología (English Edition), 2025 -- Cardiovascular disease in IBD
2. Risk of stroke in patients with inflammatory bowel disease: a systematic review and meta-analysis | BMC Gastroenterology, 2025 -- Stroke risk in IBD
3. Frontiers in Immunology — The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease
4. Clinical Research in Cardiology — Reply to the Editorial Correspondence: "Cardiovascular Magnetic Resonance Imaging Detects Myocardial Involvement in Patients with Active Inflammatory Bowel Disease" (CRCD-D-24–01694)
5. European Radiology — CT-derived attenuation index of peribowel fat tissue as a predictor of disease advancement in patients with inflammatory bowel disease
6. Frontiers in Oncology — Visceral fat area and blood lipids in colorectal cancer: predictors of surgical risk and prognosis
7. Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU) position paper on cardiovascular disease in patients with inflammatory bowel disease | Gastroenterología y Hepatología (English Edition)
8. Risk of stroke in patients with inflammatory bowel disease: a systematic review and meta-analysis | BMC Gastroenterology | Springer Nature Link
9. Ultrasound-measured visceral adipose tissue thickness and carotid atherosclerosis in patients with inflammatory bowel diseases - ScienceDirect